New chair for UK device safety advisory body
This article was originally published in SRA
John Perrins, a consultant cardiologist with broad experience of cardiac devices and procedures, is to be the new chair of the UK Medicines and Healthcare products Regulatory Agency advisory body, the Committee on the Safety of Devices1. When Dr Perrins takes up the post in April, he will succeed John Williams, who has been chair of the committee since it was set up in 20012.
You may also be interested in...
EU marketing applications from Vertex and Roche have reverted to standard review timelines at the European Medicines Agency. The outcomes of three fast-track requests that companies have made for their planned filings are still unknown.
Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.
KTE-X19, Kite’s potential new CAR-T therapy, will in the end be fast-tracked at the European Medicines Agency. Lilly failed to secure the speedy review it was seeking for selpercatinib